Royal Bank of Canada’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$153M Buy
625,000
+105,000
+20% +$24.5M 0.03% 490
2025
Q4
$108M Sell
520,000
-60,800
-10% -$12M 0.02% 619
2025
Q3
$108M Buy
580,800
+70,800
+14% +$12.1M 0.02% 646
2025
Q2
$77.9M Sell
510,000
-260,000
-34% -$40M 0.01% 734
2025
Q1
$128M Buy
770,000
+755,000
+5,033% +$118M 0.03% 468
2024
Q4
$2.17M Sell
15,000
-1,400
-9% -$217K ﹤0.01% 2970
2024
Q3
$2.66M Sell
16,400
-5,200
-24% -$828K ﹤0.01% 2781
2024
Q2
$3.16M Buy
21,600
+6,600
+44% +$982K ﹤0.01% 2548
2024
Q1
$2.37M Sell
15,000
-45,000
-75% -$7.16M ﹤0.01% 2783
2023
Q4
$9.4M Hold
60,000
﹤0.01% 1762
2023
Q3
$9.35M Buy
60,000
+45,000
+300% +$7.43M ﹤0.01% 1627
2023
Q2
$2.48M Buy
+15,000
New +$2.42M ﹤0.01% 2663
2023
Q1
Sell
-35,000
Closed -$6.18M 7268
2022
Q4
$6.18M Buy
+35,000
New +$6.04M ﹤0.01% 1970
2022
Q2
Sell
-993,600
Closed -$176M 7542
2022
Q1
$176M Buy
993,600
+467,300
+89% +$79.5M 0.04% 328
2021
Q4
$90M Buy
+526,300
New +$86.2M 0.02% 567
2020
Q3
Sell
-41,600
Closed -$5.85M 6777
2020
Q2
$5.85M Sell
41,600
-984,000
-96% -$143M ﹤0.01% 1822
2020
Q1
$134M Buy
1,025,600
+974,200
+1,895% +$138M 0.06% 244
2019
Q4
$7.5M Sell
51,400
-293,300
-85% -$39.8M ﹤0.01% 1842
2019
Q3
$44.6M Buy
344,700
+158,900
+86% +$20.9M 0.02% 639
2019
Q2
$25.9M Buy
185,800
+151,200
+437% +$20.9M 0.01% 923
2019
Q1
$4.84M Sell
34,600
-5,700
-14% -$764K ﹤0.01% 2036
2018
Q4
$5.2M Buy
40,300
+7,300
+22% +$1.02M ﹤0.01% 1946
2018
Q3
$4.56M Sell
33,000
-75,000
-69% -$9.97M ﹤0.01% 2180
2018
Q2
$13.1M Sell
108,000
-15,000
-12% -$1.87M 0.01% 1346
2018
Q1
$15.8M Sell
123,000
-2,200
-2% -$297K 0.01% 1248
2017
Q4
$17.5M Buy
125,200
+63,500
+103% +$8.84M 0.01% 1218
2017
Q3
$8.02M Buy
61,700
+52,800
+593% +$7M ﹤0.01% 1684
2017
Q2
$1.18M Sell
8,900
-2,300
-21% -$293K ﹤0.01% 2995
2017
Q1
$1.4M Sell
11,200
-430,200
-97% -$51.4M ﹤0.01% 2819
2016
Q4
$50.9M Buy
441,400
+105,300
+31% +$12.2M 0.03% 505
2016
Q3
$39.7M Sell
336,100
-649,600
-66% -$78.8M 0.02% 606
2016
Q2
$120M Buy
985,700
+166,900
+20% +$19M 0.07% 215
2016
Q1
$88.6M Buy
818,800
+464,500
+131% +$48.1M 0.06% 278
2015
Q4
$36.4M Buy
354,300
+79,300
+29% +$7.97M 0.02% 593
2015
Q3
$25.7M Buy
+275,000
New +$26.6M 0.02% 635
2015
Q2
Sell
-55,000
Closed -$5.53M 6651
2015
Q1
$5.53M Buy
+55,000
New +$5.59M ﹤0.01% 1541
2014
Q4
Sell
-47,400
Closed -$5.05M 6235
2014
Q3
$5.05M Buy
47,400
+28,800
+155% +$2.99M ﹤0.01% 1647
2014
Q2
$1.95M Sell
18,600
-71,100
-79% -$7.19M ﹤0.01% 2314
2014
Q1
$8.81M Buy
+89,700
New +$8.32M 0.01% 1233
2013
Q4
Sell
-50,000
Closed -$4.33M 6027
2013
Q3
$4.33M Hold
50,000
﹤0.01% 1667
2013
Q2
$4.29M Buy
+50,000
New +$4.24M ﹤0.01% 1555

Other funds holding JNJ

Royal Bank of Canada's JNJ Position: Q1 2026 in Review

Royal Bank of Canada reduced its Johnson & Johnson (JNJ) stake by 6.3% in Q1 2026, selling an estimated $210M and leaving 13,387,402 shares worth $3.27B. The position accounts for 0.57% of the portfolio, ranked #33.

Royal Bank of Canada first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,632 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Royal Bank of Canada held 13,387,402 shares of Johnson & Johnson worth $3.27B as of Q1 2026.
  • Royal Bank of Canada sold 900,159 Johnson & Johnson shares in Q1 2026, an estimated $210M.
  • Johnson & Johnson made up 0.57% of Royal Bank of Canada's portfolio in Q1 2026, its #33 holding.
  • Royal Bank of Canada first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,632 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.